Christopher J Luneau

Title: Christopher J Luneau: Innovator in Adenosine Receptor Research

Introduction

Christopher J Luneau is a notable inventor based in Lansdale, PA (US). He has made significant contributions to the field of biochemistry, particularly in the area of human adenosine receptors. With a total of 3 patents to his name, Luneau's work has implications for drug discovery and therapeutic applications.

Latest Patents

Luneau's latest patents focus on recombinant human adenosine receptors A1, A2a, A2b, and A3. These inventions involve the preparation of these receptors through cDNA cloning and polymerase chain reaction techniques. Additionally, the patents describe expression systems for these receptors and assays that utilize these systems. The recombinant adenosine receptors can be employed in assays to identify and evaluate entities that bind to or enhance binding to adenosine receptors.

Career Highlights

Christopher J Luneau is currently associated with Merck & Co., Inc., where he continues to advance research in his field. His work has been instrumental in enhancing the understanding of adenosine receptors and their potential applications in medicine.

Collaborations

Luneau has collaborated with notable colleagues, including Marlene A Jacobson and Robert G Johnson. These partnerships have contributed to the success of his research and the development of innovative solutions in biochemistry.

Conclusion

Christopher J Luneau's contributions to the field of adenosine receptor research highlight his role as an influential inventor. His patents and ongoing work at Merck & Co., Inc. continue to pave the way for advancements in therapeutic applications.